血清癌抗原125联合人血清附睾蛋白4对卵巢恶性肿瘤的检测价值(3)
[4] 刘中娟，丁金文，成宁海.人附睾分泌蛋白4对卵巢恶性肿瘤的诊断价值[J].标记免疫分析与临床，2010，17(5)：292-296.
[5] 张鹏，马永能，刘慧玲，等.糖类抗原检测在卵巢肿瘤早期诊断中的临床价值[J].检验医学与临床，2011，8(19)：2308-2309.
[6] Scholler N，Crawford M，Sato A，et al. Bead-based ELISA for validation of ovarian cancer early detection markers [J]. Clinical Cancer Research，2006，12(7 pt1)：2117-2124.
[7] Yin BW，Lloyd KO. Melecular clonity of the CA125 ovarian cancer antigen： identification as a new mucin，Muc16 [J]. J Biol Chem，2001，276(29)：71-75.
[8] Hellstrom I，Raycraft J，Schummer M，et al. The HE4(WFDC2)protein is a biomarker for ovarian carcinoma [J]. Cancer Res，2003，63：3695-3700.
[9] Israeli O，Goldring Aviram A，Rienstein S，et al. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer [J]. Cancer Genet Cytogenet，2005，160(1)： 35-42.
[10] Galgano MT，Hampton GM，Frierson HF，et al. Comprehensive analysis of HE4 expression in normal and malignant human tissues [J]. Mod Pathol，2006，19：847-853.
[11] Barbieri RL. In women who have a pelvic massHave you tried this new ovarian Ca biomarker? [J]. OBG Management，2010，22(4)：8-12.
[12] Bouchard D，Morisset D，Bourbonnais Y，et al. Proteins with whey acidic protein motifs and cancer [J]. Lancet Onco，2006，7(2)：167-174.
[13] Gilks CB，Vanderhyden BC，Zhu S，et al. Distinction between serous tumors of low malignant potential and serous carcinomas based on globalm RNA expression profiling[J]. Gynecologic Oncol，2005，96(3)：684-694.
(收稿日期：2012-02-24 本文编辑：冯 婕), http://www.100md.com(许惠根 袁春雷)
[5] 张鹏，马永能，刘慧玲，等.糖类抗原检测在卵巢肿瘤早期诊断中的临床价值[J].检验医学与临床，2011，8(19)：2308-2309.
[6] Scholler N，Crawford M，Sato A，et al. Bead-based ELISA for validation of ovarian cancer early detection markers [J]. Clinical Cancer Research，2006，12(7 pt1)：2117-2124.
[7] Yin BW，Lloyd KO. Melecular clonity of the CA125 ovarian cancer antigen： identification as a new mucin，Muc16 [J]. J Biol Chem，2001，276(29)：71-75.
[8] Hellstrom I，Raycraft J，Schummer M，et al. The HE4(WFDC2)protein is a biomarker for ovarian carcinoma [J]. Cancer Res，2003，63：3695-3700.
[9] Israeli O，Goldring Aviram A，Rienstein S，et al. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer [J]. Cancer Genet Cytogenet，2005，160(1)： 35-42.
[10] Galgano MT，Hampton GM，Frierson HF，et al. Comprehensive analysis of HE4 expression in normal and malignant human tissues [J]. Mod Pathol，2006，19：847-853.
[11] Barbieri RL. In women who have a pelvic massHave you tried this new ovarian Ca biomarker? [J]. OBG Management，2010，22(4)：8-12.
[12] Bouchard D，Morisset D，Bourbonnais Y，et al. Proteins with whey acidic protein motifs and cancer [J]. Lancet Onco，2006，7(2)：167-174.
[13] Gilks CB，Vanderhyden BC，Zhu S，et al. Distinction between serous tumors of low malignant potential and serous carcinomas based on globalm RNA expression profiling[J]. Gynecologic Oncol，2005，96(3)：684-694.
(收稿日期：2012-02-24 本文编辑：冯 婕), http://www.100md.com(许惠根 袁春雷)